HDFC Nifty LargeMidcap 250 Index Fund vs NH

Portfolio Overlap Analysis · HDFC vs Nippon

5.1%
Low Overlap
15 common stocks · Rank #28032 of 28,292 pairs
Fund A
HDFC Nifty LargeMidcap 250 Index Fund
HDFC · Large & Mid Cap
Fund B
NH
Nippon · Equity - Other

Common Holdings (10)

StockWt% in HDFC Nifty LargeMidcap 250 IndWt% in NHOverlap
Lupin Limited
Pharmaceuticals & Biotechnology
6.65%0.74%0.74%
Sun Pharmaceutical Industries Limited
Pharmaceuticals & Biotechnology
21.93%0.66%0.66%
Aurobindo Pharma Limited
Pharmaceuticals & Biotechnology
4.07%0.45%0.45%
Alkem Laboratories Limited
Pharmaceuticals & Biotechnology
3.93%0.44%0.44%
Glenmark Pharmaceuticals Limited
Pharmaceuticals & Biotechnology
3.84%0.43%0.43%
Biocon Limited
Pharmaceuticals & Biotechnology
3.32%0.37%0.37%
Mankind Pharma Limited
Pharmaceuticals & Biotechnology
3.03%0.34%0.34%
Divi's Laboratories Limited
Pharmaceuticals & Biotechnology
9.71%0.29%0.29%
Dr. Reddy's Laboratories Limited
Pharmaceuticals & Biotechnology
9.35%0.28%0.28%
IPCA Laboratories Limited
Pharmaceuticals & Biotechnology
2.53%0.28%0.28%

Unique to HDFC Nifty LargeMidcap 250 Ind

  • HDFC Bank Ltd.4.88%
  • ICICI Bank Ltd.3.54%
  • Reliance Industries Ltd.3.38%
  • Bharti Airtel Ltd.1.88%
  • Larsen and Toubro Ltd.1.81%
  • State Bank of India1.79%
  • Infosys Limited1.64%
  • Bombay Stock Exchange Limited (BSE)1.47%
  • Axis Bank Ltd.1.43%
  • Kotak Mahindra Bank Limited1.10%

Unique to NH

  • Cipla Limited9.04%
  • Torrent Pharmaceuticals Limited5.40%
  • Laurus Labs Limited4.98%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
5.1% (15)

Analysis

AI-generated comparative analysis coming soon.

More comparisons for HDFC Nifty LargeMidcap 250 Ind

More comparisons for NH

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.